Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Oral Azacitidine for Acute Myeloid Leukemia
Recruiting3 awardsPhase 4
Richmond, Virginia
This trial will test if giving oral medication to AML patients after their first round of treatment is a feasible option. These patients are eligible for a transplant but may face challenges due to lack of medical resources
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.